Page 25 - Bharat Biotech
Covid vaccine updates: Key facts and major announcements you should know
All people of the country will be given Covid vaccine for free, Union Minister Pratap Sarangi announced on Sunday
Bharat Biotech starts Covaxin's at-risk manufacturing; expanding capacity
The first vaccine candidate will be an intra-muscular one, followed by intra-dermal and nasal ones, depending on test results.
Bharat Biotech in talks with over 10 nations to take Covid vaccine global
Read more at: https://www.deccanherald.com/business/indias-bharat-biotech-in-talks-to-take-vaccine-candidate-covaxin-global-906089.html
Bharat Biotech gets go-ahead to conduct Phase-III trials of Covaxin
The around 28,500 people expected to enrol for the Phase-III trials would be given two doses of the investigational vaccine
Covaxin: Bharat Biotech's Covid vaccine candidate gets Phase 3 trials nod
In a statement published on its website, the panel said it recommended granting the approval after studying the firm's Phase I and II data along with 'animal challenge data in two species'
Covid-19: Bharat Biotech cuts Covaxin phase-2 clinical trial size by half
For phase-2 studies, the firm is also testing the vaccine on children above 12 years of age. In phase-1, they only tested adults.
Indian samples of global Covid-19 vaccines need to be larger: Experts
Indian players like Bharat Biotech and Zydus Cadila ready for large-scale phase-3 trials
Inhaled vaccines aim to target coronavirus at its point of invasion
Most vaccines in human testing require two shots for effectiveness, and developers still aren't even sure if they'll prevent infections
Govt may allow use of Covid vaccine in emergency situations: Harsh Vardhan
Warns of spike in cases during winter; China, UAE among the few countries have allowed such authorisation
Bharat Biotech told to submit complete phase 2 data of its Covid-19 vaccine
Bharat Biotech, which had sought DCGI's nod for conducting phase-3 clinical trials of its Covid-19 vaccine candidate, has been asked to submit complete data of the ongoing phase-2 trial
Repurposing capacity for Covid-19 vaccine, say Indian pharma firms
Suresh Jadhav, executive director of the Serum Institute of India (SII), said the biotechnology company has already put in place an expansion plan for new products in the pipeline
ICMR launches a new vaccine portal for Covid, with details of trials
The portal covers other ailments as well; will provide details of progress made locally and globally at regular intervals
Bharat Biotech aims at billion Covaxin doses a year, phase-3 trials in Oct
Firm also ties up with Washington University's school of medicine for intransal vaccine for Covid-19
Bharat Biotech inks deal with Washington varsity for intranasal Covid vax
Bharat Biotech on Wednesday announced a licensing agreement with Washington University School of Medicine in St. Louis for a novel chimp-adenovirus, single dose intranasal vaccine for Covid-19
Govt in talks with Russia for advancement of Covid-19 vaccine: Health Min
The Central Drugs Standard Control Organisation (CDSCO) has informed that it has received information about one Covid-19 vaccine developed and approved in Russia
India's Covid-19 tally nears 5 mn with one-fifth of total cases active
India took six months to reach the first million covid cases and it has gone from four to 4.9 million in 11 days
Bharat Biotech's Covaxin succeeds in challenge trials on Rhesus monkeys
The results showed protective efficacacy, increasing Sars-CoV-2 specific IgG and neutralising antibodies reducing the replication of the virus in the nasal cavity, throat and lung tissues of monkey
Telangana to get priority in Bharat Biotech's Covid-19 vaccine supply: KCR
Telangana CM K Chandrashekhar Rao said his government was ensuring that Telangana, as the home state, gets priority in supply of Covid-19 vaccine as and when it is manufactured by Bharat Biotech
PGI Rohtak to start phase-2 trial of Bharat Biotech's Covid-19 vaccine
Post Graduate Institute (PGI) Rohtak will start the phase-2 human clinical trial of Bharat Biotech's COVID-19 vaccine
Phase II clinical trials of Bharat Biotech's Covid-19 vaccine from Sept 7
These trials of the BBV152 coronavirus vaccine or Covaxin will be conducted on 380 participants, who will have to be screened for four days after they receive the vaccine shots
